Freenome’s $300 Million Series D Financing

Fenwick & West advised Freenome on the deal.Freenome, a privately held biotechnology company, announced its $300million Series D financing. The round was led by investors Perceptive Advisors…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now